Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-ranging study of Furazidin vaginal tablets in women with bacterial vaginosis
2021-004579-16Phase 2Completed
- Sponsor
- Adamed Pharma
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of furazidin in bacterial vaginosis (BV) (5 arms), sponsored by Adamed Pharma. Primary endpoint: Safety and local tolerability. Started Oct 2021; status: completed.
02
Drugs
furazidin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on 2021-004579-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004579-16.